Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 10:36 PM
Ignite Modification Date:
2025-12-24 @ 10:36 PM
NCT ID:
NCT02896335
Brief Title:
Palbociclib and Pembrolizumab In Central Nervous System Metastases
Official Title:
Phase II Trial of Palbociclib and Pembrolizumab in Central Nervous System Metastases
Study:
NCT02896335
Protocol Section:
NCT02896335